0
     

Report Added
Report already added
Dynamics in Post-pandemic Global IBS-C Drug Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global IBS-C Drug Industry: Supply and Demand, Markets and Prices 2021-2027

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global IBS-C Drug market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global IBS-C Drug market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Other

Segmented by End User/Segment
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Yuhan Corp
The Menarini Group
Teva Pharmaceutical Industries
Synthetic Biologics
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Salix Pharmaceuticals
Prometheus Laboratories
Ono Pharmaceutical
Novartis Pharma
Norgine
Nestle
Ironwood Pharmaceuticals
Ferring BV
Catalent Pharmaceuticals Solutions
Bama-Geve
Astrazeneca
Astellas Pharmaceuticals
Ardelyx
Albireo Pharma
Actavis Nordic
Abbott Laboratories

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global IBS-C Drug Market Status and Forecast (2016-2027)
1.3.2 Global IBS-C Drug Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global IBS-C Drug Supply by Company
2.1 Global IBS-C Drug Sales Volume by Company
2.2 Global IBS-C Drug Sales Value by Company
2.3 Global IBS-C Drug Price by Company
2.4 IBS-C Drug Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional IBS-C Drug Market Status by Category
3.1 IBS-C Drug Category Introduction
3.1.1 Linaclotide
3.1.2 Lubiprostone
3.1.3 Osmotic Laxatives
3.1.4 Stimulant Laxatives
3.1.5 Other
3.2 Global IBS-C Drug Market by Category
3.2.1 Global IBS-C Drug Sales Volume by Category (2016-2021)
3.2.2 Global IBS-C Drug Sales Value by Category (2016-2021)
3.2.3 Global IBS-C Drug Price by Category (2016-2021)
3.3 North America: by Category
3.4 Europe: by Category
3.5 Asia Pacific: by Category
3.6 Central & South America: by Category
3.7 Middle East & Africa: by Category
4 Global and Regional IBS-C Drug Market Status by End User/Segment
4.1 IBS-C Drug Segment by End User/Segment
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global IBS-C Drug Market by End User/Segment
4.2.1 Global IBS-C Drug Sales Volume by End User/Segment (2016-2021)
4.2.2 Global IBS-C Drug Sales Value by End User/Segment (2016-2021)
4.2.3 Global IBS-C Drug Price by End User/Segment (2016-2021)
4.3 North America: by End User/Segment
4.4 Europe: by End User/Segment
4.5 Asia Pacific: by End User/Segment
4.6 Central & South America: by End User/Segment
4.7 Middle East & Africa: by End User/Segment
5 Global IBS-C Drug Market Status by Region
5.1 Global IBS-C Drug Market by Region
5.1.1 Global IBS-C Drug Sales Volume by Region
5.1.2 Global IBS-C Drug Sales Value by Region
5.2 North America IBS-C Drug Market Status
5.3 Europe IBS-C Drug Market Status
5.4 Asia Pacific IBS-C Drug Market Status
5.5 Central & South America IBS-C Drug Market Status
5.6 Middle East & Africa IBS-C Drug Market Status
6 North America IBS-C Drug Market Status
6.1 North America IBS-C Drug Market by Country
6.1.1 North America IBS-C Drug Sales Volume by Country (2016-2021)
6.1.2 North America IBS-C Drug Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe IBS-C Drug Market Status
7.1 Europe IBS-C Drug Market by Country
7.1.1 Europe IBS-C Drug Sales Volume by Country (2016-2021)
7.1.2 Europe IBS-C Drug Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific IBS-C Drug Market Status
8.1 Asia Pacific IBS-C Drug Market by Country
8.1.1 Asia Pacific IBS-C Drug Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific IBS-C Drug Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America IBS-C Drug Market Status
9.1 Central & South America IBS-C Drug Market by Country
9.1.1 Central & South America IBS-C Drug Sales Volume by Country (2016-2021)
9.1.2 Central & South America IBS-C Drug Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa IBS-C Drug Market Status
10.1 Middle East & Africa IBS-C Drug Market by Country
10.1.1 Middle East & Africa IBS-C Drug Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa IBS-C Drug Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 IBS-C Drug Manufacturing Cost Analysis
11.5 IBS-C Drug Sales Channel and Distributors Analysis
11.5.1 IBS-C Drug Sales Channel
11.5.2 IBS-C Drug Distributors
11.6 IBS-C Drug Downstream Major Buyers
12 Global IBS-C Drug Market Forecast by Category and by End User/Segment
12.1 Global IBS-C Drug Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global IBS-C Drug Forecast by Category
12.2.1 Global IBS-C Drug Sales Volume Forecast by Category
12.2.2 Global IBS-C Drug Sales Value Forecast by Category
12.2.3 Global IBS-C Drug Price Forecast by Category
12.3 Global IBS-C Drug Forecast by End User/Segment
12.3.1 Global IBS-C Drug Sales Volume Forecast by End User/Segment
12.3.2 Global IBS-C Drug Sales Value Forecast by End User/Segment
12.3.3 Global IBS-C Drug Price Forecast by End User/Segment
13 Global IBS-C Drug Market Forecast by Region/Country
13.1 Global IBS-C Drug Market Forecast by Region (2022-2027)
13.1.1 Global IBS-C Drug Sales Volume Forecast by Region (2022-2027)
13.1.2 Global IBS-C Drug Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Yuhan Corp
14.1.1 Company Information
14.1.2 IBS-C Drug Product Introduction
14.1.3 Yuhan Corp IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 The Menarini Group
14.2.1 Company Information
14.2.2 IBS-C Drug Product Introduction
14.2.3 The Menarini Group IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Teva Pharmaceutical Industries
14.3.1 Company Information
14.3.2 IBS-C Drug Product Introduction
14.3.3 Teva Pharmaceutical Industries IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Synthetic Biologics
14.4.1 Company Information
14.4.2 IBS-C Drug Product Introduction
14.4.3 Synthetic Biologics IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Synergy Pharmaceuticals
14.5.1 Company Information
14.5.2 IBS-C Drug Product Introduction
14.5.3 Synergy Pharmaceuticals IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Sucampo Pharmaceuticals
14.6.1 Company Information
14.6.2 IBS-C Drug Product Introduction
14.6.3 Sucampo Pharmaceuticals IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Salix Pharmaceuticals
14.7.1 Company Information
14.7.2 IBS-C Drug Product Introduction
14.7.3 Salix Pharmaceuticals IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Prometheus Laboratories
14.8.1 Company Information
14.8.2 IBS-C Drug Product Introduction
14.8.3 Prometheus Laboratories IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 Ono Pharmaceutical
14.9.1 Company Information
14.9.2 IBS-C Drug Product Introduction
14.9.3 Ono Pharmaceutical IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 Novartis Pharma
14.10.1 Company Information
14.10.2 IBS-C Drug Product Introduction
14.10.3 Novartis Pharma IBS-C Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
14.11 Norgine
14.12 Nestle
14.13 Ironwood Pharmaceuticals
14.14 Ferring BV
14.15 Catalent Pharmaceuticals Solutions
14.16 Bama-Geve
14.17 Astrazeneca
14.18 Astellas Pharmaceuticals
14.19 Ardelyx
14.20 Albireo Pharma
14.21 Actavis Nordic
14.22 Abbott Laboratories
15 Conclusion
16 Methodology

Kindly Fill The Form Below

Report Title: Dynamics in Post-pandemic Global IBS-C Drug Industry: Supply and Demand, Markets and Prices 2021-2027


Valid Invalid number
GRD Survey

SELECT A FORMAT

ADD TO CART BUY NOW